Webinar: Integrating Biomarkers into Asthma and COPD Clinical Trials
Date: Wednesday, September 26 | Time: 11 am ET / 8 am PT | Duration: 1 hour
There is growing investment in novel pathways and mechanisms of action in the pursuit of viable biomarkers for asthma and COPD studies that will allow for accurate phenotyping of patients and their response to treatment. Currently, however, there are few real success stories.
On 26 September 2012, scientific and operations experts at PPD will provide an overview of the current science of biomarker development and the challenges and strategies for integrating biomarkers into asthma and COPD clinical development programs. The discussion will address early protocol design considerations, population and site selection strategies and integration of global central labs for sputum processing.
Louis Renzetti, Ph.D., Vice President, Strategic Lab Operations, PPD
Dr. Wesley Hicks, Senior Medical Director, Global Product Development, PPD
Sarah Roberts, Ph.D., Director, Global Regulatory Affairs, PPD